Cellebrite DI (CLBT) Research & Development (2020 - 2026)

Cellebrite DI has reported Research & Development for 7 years, with the latest figure at $43.8 million in Q2 2026.

• On a quarterly basis, Research & Development rose 13.1% year-over-year to $43.8 million in Q2 2026; TTM through Jun 2026 was $164.3 million, a 12.97% increase from a year earlier, with the FY2025 full-year figure at $154.8 million, up 16.94% from the prior year.
• Research & Development was $43.8 million for Q2 2026 at Cellebrite DI, up from $43.2 million in the prior quarter.
• The five-year high for Research & Development was $43.8 million in Q2 2026, with the low at $23.3 million in Q1 2022.
• Average Research & Development over 5 years is $32.4 million, with a median of $32.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 40.81% in 2022, then grew 5.11% in 2023.
• Over 5 years, Research & Development stood at $23.7 million in 2022, then advanced by 25.03% to $29.6 million in 2023, then rose by 20.04% to $35.5 million in 2024, then gained by 8.55% to $38.6 million in 2025, then advanced by 13.46% to $43.8 million in 2026.
• The last three Research & Development figures came in at $43.8 million (Q2 2026), $43.2 million (Q1 2026), and $38.6 million (Q4 2025), per Business Quant data.